2678 results
Magmaris Magnesium BRS: safety and performance of an advanced and innovative technology
16 May 2017 From EUROPCR 2017
Chairpersons: M.K.Y. Lee , R. Waksman
Objectives: To learn how Magmaris affects thrombogenicity, to discuss on the best implantation techniques, to review optimal indications and patient selection for Magmaris use
Interventional management of acute heart failure: which device, when and how?
17 May 2017 – From EuroPCR 2017
Will SURTAVI change my practice: TAVI for patients with intermediate risk?
16 May 2017 – From EuroPCR 2017
Will SURTAVI change my practice: TAVI for patients with intermediate risk? In this session, review the trial results for SURTAVI, learn how patient selection defines outcomes in TAVI and AVR and relate the findings of this trials to your patient population and practice.
Multiple valve interventions: combined mitral and aortic valve disease
16 May 2017 – From EuroPCR 2017
Consult this session on combined mitral and aortic valve disease that includes a LIVE demonstration from St Thomas' Hospital - London, United Kingdom.
Wrap-up interview - Successful left main PCI, what are the right tools and techniques?
From EUROPCR 2017
Why has this been called “the year” of Left Main interventions? A. Latib, O. Mendiz and Z. Ghazzal review the new maturity of an intervention which pioneer A. Grüntzig attempted years ago. Learn about the compelling data today from the EXCEL study showing non-inferiority of the endovascular approach and discover what is unique about the ongoing European Bifurcation Club’s EBC Main trial. Find out how these studies can impact on indications and eventual changes in future guidelines. From new devices – sizes and the choice of 1 or 2 stents – to experience and improved techniques, the critical elements of strategy and the choice of imaging for planning, optimisation and outcome: you’ll find the details here…
EuroPCR 2017 Opening Ceremony
16 May 2017 – From EuroPCR 2017
A warm welcome from the Course Directors J. Bax, J. Fajadet, W. Wijns to everyone attending the 2017 edition of EuroPCR that marks 40 years in Angioplasty. Enjoy the Course!
Wrap-up interview - BVS: reviewing the evidence and distilling the learnings
18 May 2017 From EUROPCR 2017
Is there an unmet need for bioresorbable scaffolds? Is leaving a metallic stent behind a “recipe for disaster”? A. Seth invites G. W. Stone and A. Latib to explore what we know today about bioresorbable scaffolds. Learn why it might be too early to judge these novel devices and the possible role played by sub-optimal technique in the higher scaffold thrombosis rate and early results. Will “PSP”, or careful attention to technique, sizing and selection criteria have a positive impact on outcomes? What about DAPT? What is emerging from current registries and what can we expect from the upcoming ABSORB IV trial? Watch now…
Coronary artery disease (CAD) in TAVI patients
16 May 2017 – From EuroPCR 2017
Consult this session on coronary artery disease in TAVI patients that include a LIVE demonstration from Saint Thomas' Hospital, London on an 87-year old female patient.
Clinical case
A 87-year-old female with CAD and aortic stenosis:
- Randomised to ACTIVATION trial
- Simplified TAVI
- Sapien 3 implanted
All you need to know about coronary physiology in 2017
18 May 2017 – From EuroPCR 2017
CTO: the role of imaging
16 May 2017 – From EuroPCR 2017